TWST.NASDAQTwist Bioscience CORP

Form 4: Twist Bioscience CEO Emily Leproust Sells Shares to Cover Tax Obligations

Sentiment:

SEC Form 4 Filing

📋All filings for Twist Bioscience CORP
🔒Login to Follow

Emily Leproust, CEO of Twist Bioscience, sold 2,340 shares of common stock on September 6, 2024, to cover tax withholding obligations related to the vesting of Restricted Stock Units.

Summary

  • On September 6, 2024, Emily M. Leproust, CEO of Twist Bioscience, sold 2,340 shares of common stock at a price of $39.161 per share.
  • The sale was executed to cover tax withholding obligations associated with the vesting of Restricted Stock Units.
  • Following the transaction, Leproust directly owns 497,253 shares of Twist Bioscience common stock.
  • Leproust also holds various employee stock options with different exercise prices and expiration dates.
  • These options include those exercisable at $5.95, $8.82, $26.66, $23.33 and $67.85.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing a routine stock sale for tax purposes, indicating a neutral sentiment.

Industry Context

This Form 4 filing is a routine disclosure of stock transactions by a company insider, in compliance with SEC regulations. It provides transparency into the trading activities of key personnel and their holdings in the company.

Stakeholder Impact

  • The sale of shares by the CEO could have a minor impact on shareholder sentiment, but is unlikely to significantly affect the company's operations or financial performance.

Key Dates

DateDescription
09/01/2020Performance stock options granted to the reporting person.
12/19/2022Performance stock options vested and became exercisable.
09/06/2024Emily Leproust sold 2,340 shares of Twist Bioscience common stock.
09/10/2024Date of the signature of the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.